Former Try Guys member Ned Fulmer recently revealed that he has been living with multiple sclerosis for 12 years, bringing public attention back to the neurological disease. His disclosure highlights how MS can remain hidden for years and why early recognition of symptoms such as numbness, tingling, and vision changes is important. Scientific evidence shows that MS is a chronic, immune-mediated condition that damages the brain and spinal cord, affecting millions worldwide. Understanding how MS develops, how it is diagnosed, and what treatment options exist can help readers recognize the impact of the disease and the value of timely medical care.
Former Try Guys member Ned Fulmer recently disclosed that he has been living with multiple sclerosis (MS) for the past 12 years. He shared the news through a YouTube video, describing the symptoms he first noticed in 2013 and the treatment that helped him regain strength. His announcement brings renewed attention to MS, a chronic neurological condition that affects millions worldwide and often begins silently in young adults.[1]
Fulmer explained that he initially experienced tingling in his hands, which gradually spread to his arms, chest, and back. Imaging soon showed lesions in his brain, and clinicians discussed the possibility of MS.
The doctor was like, ‘You probably have MS,’ and I was like, ‘What is that? Isn’t that really bad?’ I was totally in denial — didn’t want to have MS.Ned Fulmer, Former Try Guys member
After a few days, a sudden collapse at home led to hospitalisation, where he received intravenous steroids and plasma exchange.
I remember sitting in that hospital bed and it getting worse and just being so scared and wondering if I was going to be able to walk again.Ned Fulmer, Former Try Guys member
Twelve years after receiving the diagnosis, he reports that his current scans show no new areas of disease activity, though he continues to have mild sensory symptoms that fluctuate with stress and temperature changes.
MS is an immune-mediated condition in which the body mistakenly attacks myelin, the insulating layer around nerve fibres in the brain and spinal cord. Damage to this layer disrupts the flow of signals in the central nervous system, which can cause sensory changes, weakness, visual disturbances, and fatigue.[1]
Evidence shows that MS begins through an interaction of genetic susceptibility and environmental triggers. Research has identified several contributing factors, including Epstein–Barr virus infection, low vitamin D levels, and smoking.[2] Although these risks are known, the exact cause is still not fully understood.
MS most often affects people between 20 and 40 years of age, the period during which Fulmer also developed his first symptoms. Women are diagnosed more frequently than men, though the condition can occur in any demographic group.[2]
Many individuals, including Fulmer, experience relapsing–remitting MS, where symptoms flare and then improve. Other patterns include primary progressive and secondary progressive MS. Over time, persistent inflammation can lead to the gradual loss of nerve fibres, which may affect long-term function.[3]
Clinicians emphasize that early recognition is critical. Disease-modifying therapies can reduce relapse rates, limit new lesions, and help preserve neurological function. Starting treatment early leads to better long-term outcomes, even though no cure currently exists.[2]
Management combines acute care during relapses, long-term immune-modifying medications, and support for daily symptoms. Rehabilitation, fatigue management, bladder care, and lifestyle adjustments often play a significant role in maintaining quality of life.[1]
Fulmer’s decision to speak openly about MS highlights how the condition may remain invisible for years while still affecting daily life. His story may encourage others with early or unexplained symptoms to seek medical care promptly. It also brings public attention to a disease that requires continuous monitoring, evidence-based treatment, and awareness.
1. Ghasemi N, Razavi S, Nikzad E. Multiple Sclerosis: Pathogenesis, Symptoms, Diagnoses and Cell-Based Therapy. Cell J. 2017 Apr-Jun;19(1):1-10. doi: 10.22074/cellj.2016.4867. Epub 2016 Dec 21. PMID: 28367411; PMCID: PMC5241505.
2. Dobson R, Giovannoni G. Multiple sclerosis - a review. Eur J Neurol. 2019 Jan;26(1):27-40. doi: 10.1111/ene.13819. Epub 2018 Nov 18. PMID: 30300457.
3. Ali Msheik, Zeinab Al Mokdad, Reem Hmede, Rami Atat. Advances in the understanding and management of multiple sclerosis phenotypes. Health Sciences Review. Volume 16. 2025.
(Rh/SS/MSM)